Search research articles
Contact Us
Filters
Showing results (41-50 of 144) with videos related to
Page
of 15
Sort By:
JAMA
|
July 29, 2004
Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis
Catherine Delbaldo, Stefan Michiels, Nathalie Syz, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
September 30, 2016
Extrapolation of Survival Curves from Cancer Trials Using External Information
Patricia Guyot, Anthony E Ades, Matthew Beasley, et al.
Bulletin Du Cancer
|
February 21, 2004
[Adjuvant chemotherapy in non-small cell lung cancer]
Laurent Taillade, Jean-Charles Soria, Fabrice André, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 22, 2005
Letter to the editor
Sarah Burdett, Lesley Stewart, Richard Stephens, et al.
The Cochrane Database of Systematic Reviews
|
October 19, 2007
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease
Catherine Delbaldo, Stefan Michiels, Estelle Rolland, et al.
The Cochrane Database of Systematic Reviews
|
April 20, 2012
WITHDRAWN: Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease
Catherine Delbaldo, Stefan Michiels, Estelle Rolland, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 5, 2017
Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project
Pernille Lassen, Benjamin Lacas, Jean-Pierre Pignon, et al.
Journal of Clinical Epidemiology
|
July 19, 2015
How individual participant data meta-analyses have influenced trial design, conduct, and analysis
Jayne F Tierney, Jean-Pierre Pignon, Francois Gueffyier, et al.
Biometrics
|
February 19, 2016
Joint model for left-censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000-05 trial
Agnieszka Król, Loïc Ferrer, Jean-Pierre Pignon, et al.
Annals of Surgical Oncology
|
March 3, 2004
Results of R0 resection for colorectal liver metastases associated with extrahepatic disease
Dominique Elias, Lucas Sideris, Marc Pocard, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 144) with videos related to
Sort By:
Page
of 15
JAMA
|
July 29, 2004
Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis
Catherine Delbaldo, Stefan Michiels, Nathalie Syz, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
September 30, 2016
Extrapolation of Survival Curves from Cancer Trials Using External Information
Patricia Guyot, Anthony E Ades, Matthew Beasley, et al.
Bulletin Du Cancer
|
February 21, 2004
[Adjuvant chemotherapy in non-small cell lung cancer]
Laurent Taillade, Jean-Charles Soria, Fabrice André, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 22, 2005
Letter to the editor
Sarah Burdett, Lesley Stewart, Richard Stephens, et al.
The Cochrane Database of Systematic Reviews
|
October 19, 2007
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease
Catherine Delbaldo, Stefan Michiels, Estelle Rolland, et al.
The Cochrane Database of Systematic Reviews
|
April 20, 2012
WITHDRAWN: Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease
Catherine Delbaldo, Stefan Michiels, Estelle Rolland, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 5, 2017
Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project
Pernille Lassen, Benjamin Lacas, Jean-Pierre Pignon, et al.
Journal of Clinical Epidemiology
|
July 19, 2015
How individual participant data meta-analyses have influenced trial design, conduct, and analysis
Jayne F Tierney, Jean-Pierre Pignon, Francois Gueffyier, et al.
Biometrics
|
February 19, 2016
Joint model for left-censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000-05 trial
Agnieszka Król, Loïc Ferrer, Jean-Pierre Pignon, et al.
Annals of Surgical Oncology
|
March 3, 2004
Results of R0 resection for colorectal liver metastases associated with extrahepatic disease
Dominique Elias, Lucas Sideris, Marc Pocard, et al.
Page
of 15